Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
EVAKSINE AS
AS
Active
Org 921746318
Grundingen 2, 0250
Oslo
Other human health activities n.e.c.
·
NACE 8699
Est. 2018 · 7 years old
2 employees
Overvåg
Share
Norway
/
Companies
/
Other human health activities n.e.c.
/
EVAKSINE AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
3M
5M
7M
3M
2020
2M
2021
1M
2022
3M
2023
6M
2024
EBITDA
NOK millions
3M
2M
1M
-0M
-1M
2M
2020
0M
-100%
2021
0M
0%
2022
0M
0%
2023
-1M
-100%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 956
1 619
1 486
3 135
5 582
Staff expenses
−351
−764
−338
−847
−900
EBITDA
1 559
−187
175
−472
−577
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
1 559
−187
175
−472
−577
Net financials
−1
−0
1
−1
−0
Profit before tax
1 558
−187
176
−473
−578
Tax
336
−0
−0
−0
−0
Net profit
1 222
−187
176
−473
−578
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 393
1 691
574
499
355
Equity
1 839
1 652
30
−443
−1 021
Long-term debt
0
0
402
389
414
Short-term debt
555
39
143
336
962
Total debt
555
39
544
725
1 376
Financial ratios
5-year trend
EBITDA-margin
-10.3%
This company
15.8%
Market median
-165% vs market
2020
2024
Soliditetsgrad
-287.2%
This company
38.2%
Market median
-852% vs market
2020
2024
Egenkapitalforrentning
-57754100.0%
This company
18.4%
Market median
-313881078% vs market
2020
2024
Nettoresultatgrad
-10.3%
This company
8.1%
Market median
-227% vs market
2020
2024
Aktivomsætning
15.71×
This company
1.12×
Market median
+1303% vs market
2020
2024
Gæld/egenkapital
1.35×
This company
0.62×
Market median
-118% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on EVAKSINE AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
